FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562819987> ?p ?o ?g. }

• W2562819987 abstract "Abstract Abstract 2645 Primary mediastinal B-cell lymphoma (PMBL) is a separate entity of aggressive B-cell lymphoma and accounts for about 5% of aggressive lymphomas according to the World Health Organization (WHO) classification. This lymphoma affects young patients and presents as a anterior mediastinal mass consisting of large B-cells that usually express little if any surface or cytoplasmic immunoglobulin and major histocompatibility complex class I and/or class II molecules. PMBL display constitutive activation of janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, also observed in Hodgkin lymphoma and is characterized by heterozygous missense mutations of STAT6 DNA binding domain that are not observed in diffuse large B-cell lymphoma. To determine whether these mutations could represent a diagnostic or prognostic marker useful in the clinic, we developed a PCR HRM (High Resolution Melting) assay to screen for mutations in STAT6 exon 12, which had been previously identified as a hotspot mutation. We analyzed a series of 80 patients with a mediastinal biopsy and/or histological review of PMBL, enrolled in clinical trials of the GELA (LNH-03) or the GOELAMS (075). DNAs were extracted from FFPE (formalin-fixed and paraffin-embedded) samples with QIAmp DNA mini kit (QIAGEN®) for GELA samples and fully automated Siemens Healthcare Diagnostics proprietary experimental method based on magnetic beads for GOELAMS samples. Sixteen DNAs were not analyzed due to poor amplification in PCR and four DNAs were not analyzed due to other reasons (refused protocol, inclusion at relapse, not included in the tissue microarray/TMA). All cases with abnormal denaturation curves were analyzed by Sanger sequencing. Of the remaining 60 DNA samples, we detected 20 mutated tumors in exon 12 (30%). These mutations were heterozygous single nucleotide variants, often multiple (10 cases, 8 double hit mutations and 2 triple hit mutations) and targeted mostly amino acids 417 (9 hits) and 419 (7 hits). Immunohistochemical analysis of TMA showed that the mutated tumors expressed CD23 (14/20) and MAL proteins (13/15), more frequently than non-mutated ones (10/33, p= 0.009 and 15/27, p=0.049, respectively). Interestingly, these proteins are encoded by genes belonging to the transcriptional signature of PMBL as defined by gene expression profiling in previous studies, There were no significant difference in the clinical presentation between patients with a STAT6 mutation and non-mutated cases regarding age, sex, performance status, Ann Arbor stage, LDH, IPI, treatment response, progression free survival and overall survival. However we noted an absence of elevated β2-microglobulin (1 case elevated/18) and an absence of albumin < 35 g/dl (0 case/8) in the mutated tumors compared with non-mutated tumors (11/31, p= 0.003 and 9/21, p< 0.05, respectively). Finally, we analyzed the correlations of these mutations with cytogenetic abnormalities including CIITA (Class II Transactivator) rearrangement, PD-L1/2 (Programmed death ligand) rearrangement and PD-L1/2 copy number alterations. Indeed, CIITA rearrangements have been described in 38% of PMBL and PD-L1/2 amplification were reported in 63% of PMBL. In this series of patients, CIITA rearrangements were present in 15/49 (31%) and PD-L1/2 low (3–4 copies) and high (>4 copies) level amplification observed in 33/52 (63%) of cases. It is interesting to note that STAT6-mutated cases frequently harbor CIITA rearrangement compared to STAT6-non-mutated cases (9/18 vs 6/31, p= 0.05) as well as PD-L1/2 low level copy number gains (12/19 vs 10/32, p= 0.02), suggesting that the combination of specific genomic alterations cooperate during PMBL oncogenesis. In conclusion, the frequency of this mutation suggests an in vivo selection during PMBL lymphomagenesis. The correlations with the clinico-biological data suggest that STAT6 mutations may be searched for in routine FFPE samples and may help to establish a molecular definition of PMBL that is characterized by alterations of the JAK-STAT pathway. Further investigations are required to identify the mutational mechanisms involved and the oncogenic function associated with these mutations. Disclosures: No relevant conflicts of interest to declare." @default.
• W2562819987 created "2017-01-06" @default.
• W2562819987 creator A5003078312 @default.
• W2562819987 creator A5012900514 @default.
• W2562819987 creator A5014942120 @default.
• W2562819987 creator A5027053111 @default.
• W2562819987 creator A5031758990 @default.
• W2562819987 creator A5034473496 @default.
• W2562819987 creator A5037590260 @default.
• W2562819987 creator A5045374333 @default.
• W2562819987 creator A5048030695 @default.
• W2562819987 creator A5057049022 @default.
• W2562819987 creator A5071546755 @default.
• W2562819987 creator A5075646456 @default.
• W2562819987 date "2012-11-16" @default.
• W2562819987 modified "2023-10-01" @default.
• W2562819987 title "Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity." @default.
• W2562819987 doi "https://doi.org/10.1182/blood.v120.21.2645.2645" @default.
• W2562819987 hasPublicationYear "2012" @default.
• W2562819987 type Work @default.
• W2562819987 sameAs 2562819987 @default.
• W2562819987 citedByCount "0" @default.
• W2562819987 crossrefType "journal-article" @default.
• W2562819987 hasAuthorship W2562819987A5003078312 @default.
• W2562819987 hasAuthorship W2562819987A5012900514 @default.
• W2562819987 hasAuthorship W2562819987A5014942120 @default.
• W2562819987 hasAuthorship W2562819987A5027053111 @default.
• W2562819987 hasAuthorship W2562819987A5031758990 @default.
• W2562819987 hasAuthorship W2562819987A5034473496 @default.
• W2562819987 hasAuthorship W2562819987A5037590260 @default.
• W2562819987 hasAuthorship W2562819987A5045374333 @default.
• W2562819987 hasAuthorship W2562819987A5048030695 @default.
• W2562819987 hasAuthorship W2562819987A5057049022 @default.
• W2562819987 hasAuthorship W2562819987A5071546755 @default.
• W2562819987 hasAuthorship W2562819987A5075646456 @default.
• W2562819987 hasConcept C104317684 @default.
• W2562819987 hasConcept C142724271 @default.
• W2562819987 hasConcept C153911025 @default.
• W2562819987 hasConcept C2778559949 @default.
• W2562819987 hasConcept C2779019163 @default.
• W2562819987 hasConcept C2779134260 @default.
• W2562819987 hasConcept C2779338263 @default.
• W2562819987 hasConcept C501734568 @default.
• W2562819987 hasConcept C502942594 @default.
• W2562819987 hasConcept C54355233 @default.
• W2562819987 hasConcept C71924100 @default.
• W2562819987 hasConcept C75563809 @default.
• W2562819987 hasConcept C86803240 @default.
• W2562819987 hasConceptScore W2562819987C104317684 @default.
• W2562819987 hasConceptScore W2562819987C142724271 @default.
• W2562819987 hasConceptScore W2562819987C153911025 @default.
• W2562819987 hasConceptScore W2562819987C2778559949 @default.
• W2562819987 hasConceptScore W2562819987C2779019163 @default.
• W2562819987 hasConceptScore W2562819987C2779134260 @default.
• W2562819987 hasConceptScore W2562819987C2779338263 @default.
• W2562819987 hasConceptScore W2562819987C501734568 @default.
• W2562819987 hasConceptScore W2562819987C502942594 @default.
• W2562819987 hasConceptScore W2562819987C54355233 @default.
• W2562819987 hasConceptScore W2562819987C71924100 @default.
• W2562819987 hasConceptScore W2562819987C75563809 @default.
• W2562819987 hasConceptScore W2562819987C86803240 @default.
• W2562819987 hasLocation W25628199871 @default.
• W2562819987 hasOpenAccess W2562819987 @default.
• W2562819987 hasPrimaryLocation W25628199871 @default.
• W2562819987 hasRelatedWork W2027593947 @default.
• W2562819987 hasRelatedWork W2075704822 @default.
• W2562819987 hasRelatedWork W2159846862 @default.
• W2562819987 hasRelatedWork W2170483022 @default.
• W2562819987 hasRelatedWork W2193707124 @default.
• W2562819987 hasRelatedWork W2410819399 @default.
• W2562819987 hasRelatedWork W2542580592 @default.
• W2562819987 hasRelatedWork W2547749888 @default.
• W2562819987 hasRelatedWork W2552737367 @default.
• W2562819987 hasRelatedWork W2580247205 @default.
• W2562819987 hasRelatedWork W2584938961 @default.
• W2562819987 hasRelatedWork W2588014963 @default.
• W2562819987 hasRelatedWork W2588464722 @default.
• W2562819987 hasRelatedWork W2596210936 @default.
• W2562819987 hasRelatedWork W2699766133 @default.
• W2562819987 hasRelatedWork W2808005169 @default.
• W2562819987 hasRelatedWork W2979844721 @default.
• W2562819987 hasRelatedWork W2979861599 @default.
• W2562819987 hasRelatedWork W2980225838 @default.
• W2562819987 hasRelatedWork W2981294081 @default.
• W2562819987 isParatext "false" @default.
• W2562819987 isRetracted "false" @default.
• W2562819987 magId "2562819987" @default.
• W2562819987 workType "article" @default.